成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Nuclease, Restriktionsendodeoxyribo-, EcoRII

ECOR II Struktur
81295-15-0
CAS-Nr.
81295-15-0
Bezeichnung:
Nuclease, Restriktionsendodeoxyribo-, EcoRII
Englisch Name:
ECOR II
Synonyma:
ECOR II;Einecs 279-723-0;ECOR II RESTRICTION ENZYME;RESTRICTION ENDONUCLEASE ECOR II;RESTRICTION ENDONUCLEASES ECOR II;ecor ii from escherichia coli mv1 193;Nuclease, restriction endodeoxyribo-, EcoRII;restriction endonucleases ecor ii from escherich;RESTRICTION ENDONUCLEASES ECOR II FROM E SCHERICHIA
CBNumber:
CB8263508
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Nuclease, Restriktionsendodeoxyribo-, EcoRII Eigenschaften

storage temp. 
−20°C
Aggregatzustand
buffered aqueous glycerol solution

Sicherheit

WGK Germany  3

Nuclease, Restriktionsendodeoxyribo-, EcoRII Chemische Eigenschaften,Einsatz,Produktion Methoden

Nuclease, Restriktionsendodeoxyribo-, EcoRII Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Nuclease, Restriktionsendodeoxyribo-, EcoRII Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 19)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Career Henan Chemica Co
+86-0371-86658258 +8613203830695
laboratory@coreychem.com China 30238 58

81295-15-0(Nuclease, Restriktionsendodeoxyribo-, EcoRII)Verwandte Suche:


  • ECOR II
  • ECOR II RESTRICTION ENZYME
  • RESTRICTION ENDONUCLEASES ECOR II
  • restriction endonucleases ecor ii from escherich
  • Nuclease, restriction endodeoxyribo-, EcoRII
  • RESTRICTION ENDONUCLEASES ECOR II FROM E SCHERICHIA
  • ecor ii from escherichia coli mv1 193
  • RESTRICTION ENDONUCLEASE ECOR II
  • Einecs 279-723-0
  • 81295-15-0
  • BioChemical
  • Molecular Biology
  • Molecular Biology Enzymes
  • Restriction Endonucleases
  • 3.1.x.x Acting on esters
  • 3.x.x.x Hydrolases
  • Molecular Biology
  • Molecular Biology Enzymes
  • Molecular Biology Tested
  • Restriction EndonucleasesApplication Index
  • Restriction EnzymesEnzyme Class Index
Copyright 2019 ? ChemicalBook. All rights reserved